COMMUNIQUÉS West-GlobeNewswire

Nova Leap Health Corp. announces Closing of Strategic Acquisition in Florida

16/12/2024 - 14:33

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Dec. 16, 2024 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or “the Company”), a [...]

Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol Substitute in ActivCrystal™ Format

16/12/2024 - 14:37

The term sheet is non-binding, subject to the execution of a definitive agreement Vancouver, Canada, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), [...]

Atea Pharmaceuticals Retains Financial Advisor to Explore Strategic Partnerships

16/12/2024 - 11:00

BOSTON, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics [...]

Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera® (ceftobiprole) in the United States

16/12/2024 - 07:15

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, December 16, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of [...]

Novo Nordisk invests DKK 8.5 billion in new production facility in Odense, Denmark

16/12/2024 - 07:29

Bagsværd, Denmark, 16 December 2024 – Today, Novo Nordisk announced plans to invest 8.5 billion Danish kroner to establish a completely new production facility in Odense, Denmark. The investment marks the first time in [...]

Bavarian Nordic Enters License and Manufacturing Agreement for its Mpox Vaccine with Serum Institute of India

16/12/2024 - 07:30

Tech transfer of MVA-BN ® will help increase global mpox vaccine manufacturing capacity and further expand the equitable access to vulnerable populations. Serum Institute of India obtains license to MVA-BN for the [...]

Groupe PAT : PAT participe au projet européen de recherche « Bryomolécules »

16/12/2024 - 08:00

Vandœuvre-lès-Nancy, le 16 décembre 2024 - 08 : 00 (CET) Communiqué de presse Pour diffusion immédiate PAT participe au projet européen de recherche « Bryomolécules » Plant Advanced Technologies PAT ( Euronext Growth™- [...]

Inventiva obtient 21,4 millions d'euros complétant la première tranche du financement multi-tranches annoncé précédemment d'un montant maximum de 348 millions d'euros

16/12/2024 - 08:30

Inventiva lève un montant de 21,4 millions d'euros permettant de compléter l’émission de la première tranche d’environ 116 millions d'euros du financement en fonds propres multi-tranches d'un montant maximum de 348 [...]

Inventiva secures €21.4 million and completes the first tranche of the previously announced multi-tranche financing of up to €348 million

16/12/2024 - 08:30

Inventiva secures €21.4 million leading to completion of the first tranche of the financing for c. €116 million, part of the multi-tranche equity financing of up to €348 million announced on October 14, 2024. Proceeds [...]

Pharming announces public cash offer to the shareholders of Abliva AB

15/12/2024 - 19:45

Proposed acquisition strengthens Pharming’s late-stage pipeline with a potential first-in-disease asset Abliva’s lead product KL1333 is currently in a pivotal clinical trial, with a positive interim analysis achieved, [...]

Kellner Group Denounces False Rumors About AIM Short Selling and Demands Immediate Accountability from Incumbent Board

14/12/2024 - 22:54

Vote “ FOR ” All Four Kellner Group Nominees Today on Gold Card for Urgently Needed Change Kellner Group Owns 5.04% of Outstanding Shares and is Fully Aligned with Stockholders NEW YORK, Dec. 14, 2024 (GLOBE NEWSWIRE [...]

Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close

14/12/2024 - 06:08

Bagsværd, Denmark, 14 December 2024 — As of today, all regulatory closing conditions relating to the review of Novo Holdings A/S’s pending acquisition of Catalent, Inc. (Catalent), including expiry of the timing [...]

NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

13/12/2024 - 23:16

NAARDEN, The Netherlands and MIAMI, Dec. 13, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, [...]

Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT™ (cosibelimab-ipdl)

14/12/2024 - 00:15

UNLOXCYT is the first and only FDA-approved anti-PD-L1 treatment for advanced cutaneous squamous cell carcinoma WALTHAM, Mass., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: [...]

Rakovina Therapeutics Announces Closing of Oversubscribed $3M Private Placement

14/12/2024 - 00:50

VANCOUVER, British Columbia, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “ Company ”, “ Rakovina ”, or “ Rakovina Therapeutics ”) a biopharmaceutical company committed to advancing new [...]

CannExpo 2025: Igniting the Cannabis Lifestyle in Toronto

13/12/2024 - 20:08

TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- via IBN -- Get ready to elevate your cannabis experience at CannExpo 2025, Toronto's Cannabis Lifestyle Show, blazing into the Queen Elizabeth Building at Exhibition Place on [...]

L’édition 2024 du congrès FAAM-EUROBAT s’achève sur des avancées révolutionnaires en matière de recherche sur les allergies alimentaires et l’anaphylaxie

13/12/2024 - 20:44

ATHÈNES, Grèce, 13 déc. 2024 (GLOBE NEWSWIRE) -- L’édition 2024 du congrès FAAM-EUROBAT , organisé du 21 au 23 novembre à l’InterContinental Athenaeum d’Athènes, a rassemblé 550 participants en provenance de plus de 25 [...]

Palvella Therapeutics Announces Closing of Merger with Pieris Pharmaceuticals and Concurrent Private Placement of $78.9 Million

13/12/2024 - 20:55

Palvella Therapeutics to debut on Nasdaq under the ticker symbol “PVLA” as a publicly traded rare disease biopharmaceutical company advancing a late clinical-stage pipeline and a platform for treating serious, rare [...]

UPDATE: Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card

13/12/2024 - 21:48

Incumbent Board has Destroyed Stockholder Value and Imperiled AIM’s Future through Breaches of Fiduciary Duty and Bad Faith Actions Stock Price has Declined by More than 99%, Clinical Strategy has Failed and AIM is on [...]